Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer.

Peschel RE, Colberg JW.

Lancet Oncol. 2003 Apr;4(4):233-41. Review.

PMID:
12681267
2.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
3.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
4.

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.

Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):664-73.

PMID:
11849788
6.

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.

J Urol. 2007 Jun;177(6):2151-6; discussion 2156. Erratum in: J Urol. 2007 Sep;178(3 Pt 1):1125.

PMID:
17509305
7.

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):25-33.

PMID:
14697417
9.

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.

Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S.

BJU Int. 2012 Feb;109 Suppl 1:22-9. doi: 10.1111/j.1464-410X.2011.10827.x. Review.

10.

[Curative radiotherapy of localized prostate cancer. Treatment methods and results].

Schwarz R.

Urologe A. 2003 Sep;42(9):1212-20. Review. German.

PMID:
14504754
11.

Does brachytherapy have a role in the treatment of prostate cancer?

Grimm PD, Blasko JC, Ragde H, Sylvester J, Clarke D.

Hematol Oncol Clin North Am. 1996 Jun;10(3):653-73. Review.

PMID:
8773503
12.

High-dose-rate brachytherapy in combination with conformal external beam radiotherapy in the treatment of prostate cancer.

Zwahlen DR, Andrianopoulos N, Matheson B, Duchesne GM, Millar JL.

Brachytherapy. 2010 Jan-Mar;9(1):27-35. doi: 10.1016/j.brachy.2009.04.007. Epub 2009 Oct 20.

PMID:
19846348
13.

Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.

van Tol-Geerdink JJ, Willem Leer J, Weijerman PC, van Oort IM, Vergunst H, van Lin EN, Alfred Witjes J, Stalmeier PF.

BJU Int. 2013 Apr;111(4):564-73. doi: 10.1111/j.1464-410X.2012.11402.x. Epub 2012 Aug 10.

14.

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy.

Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.

Urology. 2002 Jul;60(1):98-103.

PMID:
12100932
15.

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer..

Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9.

PMID:
23849168
16.

Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.

Forsythe K, Blacksburg S, Stone N, Stock RG.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16.

PMID:
22099032
17.

Brachytherapy for prostate cancer: a systematic review of clinical and cost effectiveness.

Norderhaug I, Dahl O, Høisaeter PA, Heikkilä R, Klepp O, Olsen DR, Kristiansen IS, Waehre H, Bjerklund Johansen TE.

Eur Urol. 2003 Jul;44(1):40-6. Review.

PMID:
12814673
18.

Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.

Lettmaier S, Lotter M, Kreppner S, Strnad A, Fietkau R, Strnad V.

Radiother Oncol. 2012 Aug;104(2):181-6. doi: 10.1016/j.radonc.2012.07.003. Epub 2012 Jul 30.

PMID:
22853851
19.

Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.

Gomez-Veiga F, Mariño A, Alvarez L, Rodriguez I, Fernandez C, Pertega S, Candal A.

BJU Int. 2012 Feb;109 Suppl 1:17-21. doi: 10.1111/j.1464-410X.2011.10826.x. Review.

20.

Primary radiation therapy for localized prostate cancer.

Eng TY, Thomas CR, Herman TS.

Urol Oncol. 2002 Nov-Dec;7(6):239-57. Review.

PMID:
12504845

Supplemental Content

Support Center